Articles | Open Access
Vol. 6 No. 8 (2023)
|
Page No.: 01-03 |
https://doi.org/10.18535/raj.v6i8.416
Department of Cardiology B, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco
##plugins.generic.jatsParser.article.authorBio##
×
R. Ezzahraoui
Department of Cardiology B, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco
Department of Cardiology B, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco
##plugins.generic.jatsParser.article.authorBio##
×
N. Salmi
Department of Cardiology B, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco
Department of Cardiology B, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco
##plugins.generic.jatsParser.article.authorBio##
×
H. El Ouartassi
Department of Cardiology B, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco
Department of Cardiology B, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco
##plugins.generic.jatsParser.article.authorBio##
×
Z. Bourouhou
Department of Cardiology B, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco
Department of Cardiology B, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco
##plugins.generic.jatsParser.article.authorBio##
×
M. Cherti
Department of Cardiology B, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco
Abstract
Angiotensin-converting enzyme (ACE) inhibitors are widely used as antihypertensives, remodeling agents in heart failure, to stop the progression of diabetic nephropathy, as well as for a variety of other clinical purposes. Some side effects of ACE inhibitors are well recognized such as dry cough, hypotension, hyperkaliemia, proteinuria, renal failure. Also, these substances are known to have a wide range of dermatological side effects in addition to their adverse effects on other systems. (1,2)
We report the case of a 46-year-old man treated for dilated cardiomyopathy with severe left ventricle dysfunction, who developed a cutaneous reaction secondary to the introduction of an ACE inhibitor.
Downloads
Download data is not yet available.
Copyrights & License
Copyright © 2023
.
R. Ezzahraoui,
N. Salmi,
H. El Ouartassi,
Z. Bourouhou,
M. Cherti , this is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.